Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1989;74:388-392
© 1989 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DINH, T. V.
Right arrow Articles by YANDELL, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DINH, T. V.
Right arrow Articles by YANDELL, R. B.

Mixed Mullerian Tumors of the Uterus: A Clinicopathologic Study

TUNG V. DINH, MD, RICHARD E. SLAVIN, MD, BELUR S. BHAGAVAN, MD, EDWARD V. HANNIGAN, MD, ESPERANZA M. TIAMSON, MD and ROGER B. YANDELL, MD

From the Departments of Obstetrics and Gynecology and Pathology, the University of Texas, Galveston Medical Branch, Galveston, Texas; and the Department of Pathology, Sinai Hospital of Baltimore, Baltimore, Maryland

Abstract

Forty-seven cases of mixed mullerian tumors of the uterus were analyzed clinically and pathologically. AH patients but one were postmenopausal. Vaginal bleeding was the most frequent presenting symptom, followed by abdominal mass and pelvic pain. Long-term survival was found only in those cases in which the tumor was localized to the uterus (surgical stage I), particularly if it arose from a benign endometrial polyp. No correlation could be established between survival and tumor size, depth of myometrial invasion, or histologic type of sarcoma. Tumors arising after previous irradiation had a poor prognosis. Treatment included surgery, radiation, and chemotherapy. The cumulative probability of 5-year survival was 35%.




This article has been cited by other articles:


Home page
 Obstet GynecolHome page
N. Bansal, T. J. Herzog, V. E. Seshan, P. B. Schiff, W. M. Burke, C. J. Cohen, and J. D. Wright
Uterine Carcinosarcomas and Grade 3 Endometrioid Cancers: Evidence for Distinct Tumor Behavior
Obstet. Gynecol., July 1, 2008; 112(1): 64 - 70.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Obstetricians and Gynecologists.